Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma

Overview of attention for article published in Frontiers in immunology, May 2023

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,552 followers.

RT @FrontImmunol: New Research: Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibod…

24 May 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibod…

24 May 2023

Reply Repost Favourite

New Research: Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma: Background Indoleamine-2,3-dioxygenase 1 (IDO1) is responsible for tumor immune escape by… #immunology

24 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.